Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 35
Selected: 0
NCT IDTitle
NCT06567314Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma
NCT07397338Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
NCT06959550Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer
NCT06805617A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
NCT06925724A Study of Ivonescimab in People With Endometrial and Cervical Cancers
NCT06767514Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
NCT06840834Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy
NCT02784002A Study of Ridinilazole (SMT19969) Compared With Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI)
NCT07228832Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
NCT07516925A Study of Ivonescimab in People With Leiomyosarcoma
NCT06940518Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT05899608Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
NCT07094685Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer
NCT07535463A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
NCT07359456Testing Ivonescimab in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancers Without Liver Metastases
NCT07017673Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer
NCT04802837Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects
NCT07535437A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
NCT02092935A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
NCT03595553Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection
NCT06396065Phase III Study of AK112 for NSCLC Patients
NCT06846346Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma
NCT07057791Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
NCT02056808A Phase 1b Study of SMT C1100 in Subjects With Duchenne Muscular Dystrophy (DMD)
NCT07264075Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN
NCT02383511Modified Diet Trial: A Study of SMT C1100 in Paediatric Patients With DMD Who Follow a Balanced Diet
NCT05382442A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
NCT06529718Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients
NCT07070466Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
NCT02858362Proof of Concept Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With Duchenne Muscular Dystrophy (DMD)
NCT07405190Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC
NCT06672575A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
NCT07234877Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets
NCT06980077Ivonescimab for the Treatment of Thymic Cancer
NCT07619339A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer